secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2024-12-23T23:59:59+00:00
Accession:  0001615219-24-000101
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Salarius stockholders re-elect directors, approve say-on-pay, ratify auditor at annual meeting
--------------------------------------------------------------------------------

- Two Class III directors re-elected: Tess Burleson (141,974 for) and Paul Lammers (145,485 for).
- Non-binding advisory vote on named executive officer compensation approved (135,949 for, 18,637 against).
- Ratification of Ernst & Young LLP as independent auditor for FY 2024 approved (496,239 for, 59,576 against).
- Quorum of 39.7% (572,540 of 1,441,157 shares) present at December 20, 2024 meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521924000101/0001615219-24-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521924000101/flks-20241220.htm
  HTML page:      https://secwatch.observer/filing/0001615219-24-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer